Medtronic Announces Expanded Labeling for Model 407C Pump

The diabetes business unit of Medtronic has announced FDA clearance of expanded labeling for its external model 407C general medication infusion pump.

In addition to subcutaneous delivery, the infusion pump is now cleared to deliver medications labeled for intravenous and intrathecal (spinal) infusion. Similar to Medtronic's external insulin pumps used to treat diabetes, the Model 407C general medication pump is a pager-size device that delivers precise doses of medication to a patient's body.

The external pump can deliver medications to treat a variety of medical conditions including, but not limited to, cancer and pain. Currently, Medtronic's general medication pump is being used to deliver Remodulin, manufactured by United Therapeutics, for the treatment of pulmonary arterial hypertension.